“Evaluation of the Possible Role of Angiotensin Peptide (1-7) on Treatment of COVID-19” (NCT04375124): assesses the impact of Angiotensin Peptide (1-7) supplementation using Ang-(1-7) derived plasma on COVID-19 treatment, with a focus on potential Ang-(1-7) deficiency and hyperinflammation. This evidence concerns the gene ANGPT1 and COVID-19.